Suppr超能文献

含脂质A的脂质体的佐剂效应:增强脂质体抗原呈递及巨噬细胞募集。

Adjuvant effects of liposomes containing lipid A: enhancement of liposomal antigen presentation and recruitment of macrophages.

作者信息

Verma J N, Rao M, Amselem S, Krzych U, Alving C R, Green S J, Wassef N M

机构信息

Department of Membrane Biochemistry, Walter Reed Army Institute of Research, Washington, D.C. 20307-5100.

出版信息

Infect Immun. 1992 Jun;60(6):2438-44. doi: 10.1128/iai.60.6.2438-2444.1992.

Abstract

Liposomes containing lipid A induced potent humoral immune responses in mice against an encapsulated malaria antigen (R32NS1) containing NANP epitopes. The immune response was not enhanced by lipid A alone or by empty liposomes containing lipid A. Experiments to investigate the adjuvant mechanisms of liposomes and lipid A revealed that liposome-encapsulated R32NS1 was actively presented by bone marrow-derived macrophages to NANP-specific cloned T cells. The degree of presentation was related to the amount of liposomal antigen added per macrophage in the culture medium. At high cell densities, poor presentation occurred when liposomes lacked lipid A but excellent presentation occurred when the liposomes contained lipid A. Liposomes containing lipid A and encapsulated antigen also activated gamma interferon-treated macrophages to produce nitric oxide. Macrophage activation and antigen presentation occurred with liposomes that could not be detected by the Limulus amebocyte lysis assay. Intraperitoneal injection of liposomal lipid A caused a marked increase in the recruitment of immature (peroxidase-positive) macrophages to the peritoneum. On the basis of these experiments, we propose that the mechanism of the adjuvant action of liposomal lipid A is partly due to increased antigen presentation by macrophages and partly due to recruitment of an increased number of macrophages serving as antigen-presenting cells.

摘要

含有脂多糖A的脂质体在小鼠体内诱导了针对含NANP表位的包囊型疟疾抗原(R32NS1)的强烈体液免疫反应。单独的脂多糖A或含有脂多糖A的空脂质体均未增强免疫反应。研究脂质体和脂多糖A佐剂机制的实验表明,脂质体包裹的R32NS1由骨髓来源的巨噬细胞呈递给NANP特异性克隆T细胞。呈递程度与培养基中每个巨噬细胞添加的脂质体抗原量有关。在高细胞密度下,当脂质体缺乏脂多糖A时呈递较差,但当脂质体含有脂多糖A时呈递良好。含有脂多糖A和包裹抗原的脂质体还激活经γ干扰素处理的巨噬细胞产生一氧化氮。巨噬细胞激活和抗原呈递发生在鲎试剂检测无法检测到的脂质体中。腹腔注射脂质体脂多糖A导致未成熟(过氧化物酶阳性)巨噬细胞向腹膜的募集显著增加。基于这些实验,我们提出脂质体脂多糖A的佐剂作用机制部分归因于巨噬细胞抗原呈递增加,部分归因于作为抗原呈递细胞的巨噬细胞数量增加。

相似文献

3
Phagocytosis of liposomes by macrophages: intracellular fate of liposomal malaria antigen.
Biochim Biophys Acta. 1991 Jul 22;1066(2):229-38. doi: 10.1016/0005-2736(91)90191-a.
5
Lipopolysaccharide, lipid A, and liposomes containing lipid A as immunologic adjuvants.
Immunobiology. 1993 Apr;187(3-5):430-46. doi: 10.1016/S0171-2985(11)80355-4.
8
Liposomes containing lipid A: a potent nontoxic adjuvant for a human malaria sporozoite vaccine.
Immunol Lett. 1990 Aug;25(1-3):275-9. doi: 10.1016/0165-2478(90)90127-c.
9
Intracellular processing of liposome-encapsulated antigens by macrophages depends upon the antigen.
Infect Immun. 1995 Jul;63(7):2396-402. doi: 10.1128/iai.63.7.2396-2402.1995.
10

引用本文的文献

1
Mechanisms and Barriers in Nanomedicine: Progress in the Field and Future Directions.
ACS Nano. 2024 Jun 4;18(22):13983-13999. doi: 10.1021/acsnano.4c00182. Epub 2024 May 20.
2
Liposomes for malaria management: the evolution from 1980 to 2020.
Malar J. 2021 Jul 27;20(1):327. doi: 10.1186/s12936-021-03858-0.
3
Nanoparticle-Induced Complement Activation: Implications for Cancer Nanomedicine.
Front Immunol. 2021 Jan 8;11:603039. doi: 10.3389/fimmu.2020.603039. eCollection 2020.
4
Army Liposome Formulation (ALF) family of vaccine adjuvants.
Expert Rev Vaccines. 2020 Mar;19(3):279-292. doi: 10.1080/14760584.2020.1745636. Epub 2020 Mar 31.
5
Harnessing Liposome Interactions With the Immune System for the Next Breakthrough in Cancer Drug Delivery.
Front Pharmacol. 2019 Mar 12;10:220. doi: 10.3389/fphar.2019.00220. eCollection 2019.
6
The Use of Synthetic Carriers in Malaria Vaccine Design.
Vaccines (Basel). 2015 Oct 29;3(4):894-929. doi: 10.3390/vaccines3040894.
7
Enhancing nicotine vaccine immunogenicity with liposomes.
Bioorg Med Chem Lett. 2013 Feb 15;23(4):975-8. doi: 10.1016/j.bmcl.2012.12.048. Epub 2012 Dec 27.
8
Adjuvants for human vaccines.
Curr Opin Immunol. 2012 Jun;24(3):310-5. doi: 10.1016/j.coi.2012.03.008. Epub 2012 Apr 19.
10
Highly effective generic adjuvant systems for orphan or poverty-related vaccines.
Vaccine. 2011 Jan 29;29(5):873-7. doi: 10.1016/j.vaccine.2010.11.049. Epub 2010 Nov 27.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验